Diagnostic Methods and VR Therapy for Cervical Spine Discopathy
Launched by UNIVERSITY OF RZESZOW · Sep 5, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Study Design and Group Composition:
The study will involve 100 patients with cervical spine discopathy participating in a rehabilitation program at the Provincial Hospital in Tarnów, Poland.
Eligible patients will be randomly assigned to one of two groups:
Study Group (50 patients): Participants will undergo a standard rehabilitation program supplemented with additional VR therapy aimed at improving the range of motion of the cervical spine.
Control Group (50 patients): Participants will only partake in the standard rehabilitation program.
Therapeutic Program:
Number of Therapy Sessio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 to 65 years.
- • Diagnosed and confirmed cervical spine discopathy (ICD-10: M50) through imaging studies (X-ray, MRI).
- • Presence of symptoms related to cervical spine dysfunction, such as neck pain, limited range of motion, and radiating pain to the arms.
- • Informed consent to participate in the study and willingness to adhere to rehabilitation recommendations.
- Exclusion Criteria:
- • Active rheumatic diseases, cancers, advanced diabetes, cardiovascular diseases, or other conditions affecting the safety and effectiveness of rehabilitation.
- • Cervical spine surgeries performed within the last 6 months.
- • Cervical spine injuries, including fractures or dislocations.
- • Severe mental disorders.
- • Lack of informed consent to participate in the study.
About University Of Rzeszow
The University of Rzeszow is a leading academic institution dedicated to advancing research and education in the health sciences. With a robust commitment to clinical research, the university actively sponsors innovative clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging a multidisciplinary approach, the university collaborates with healthcare professionals, researchers, and industry partners to investigate novel therapies and interventions. Through its state-of-the-art facilities and expertise, the University of Rzeszow strives to contribute significantly to the development of evidence-based practices in medicine, fostering a healthier future for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rzeszów, , Poland
Rzeszów, , Poland
Patients applied
Trial Officials
Andżelina Wolan-Nieroda, PhD
Principal Investigator
University of Rzeszow
Agnieszka Guzik, Professor
Study Chair
University of Rzeszow
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported